AGP

Artia Global Partners Portfolio holdings

AUM $389M
1-Year Est. Return 34.68%
This Quarter Est. Return
1 Year Est. Return
+34.68%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$341M
AUM Growth
+$93M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
43
New
Increased
Reduced
Closed

Top Buys

1
+$78.4M
2
+$18M
3
+$13.1M
4
INSM icon
Insmed
INSM
+$11.5M
5
DGX icon
Quest Diagnostics
DGX
+$9.6M

Top Sells

1
+$17.2M
2
+$13.3M
3
+$8.04M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$7.51M
5
RVMD icon
Revolution Medicines
RVMD
+$6.36M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XENE icon
26
Xenon Pharmaceuticals
XENE
$3.25B
$1.34M 0.34%
40,000
ASND icon
27
Ascendis Pharma
ASND
$12.3B
$1.16M 0.29%
7,440
JANX icon
28
Janux Therapeutics
JANX
$1.53B
$1.03M 0.26%
38,100
-124,876
MREO
29
Mereo BioPharma
MREO
$325M
$948K 0.24%
421,359
TVTX icon
30
Travere Therapeutics
TVTX
$2.39B
$554K 0.14%
+30,900
CNTA
31
Centessa Pharmaceuticals
CNTA
$3.04B
$507K 0.13%
35,226
-45,154
ORKA
32
Oruka Therapeutics
ORKA
$1.29B
$75.7K 0.02%
+7,380
ANNX icon
33
Annexon
ANNX
$334M
– –
-172,226
CRL icon
34
Charles River Laboratories
CRL
$9.26B
– –
-6,305
CRNX icon
35
Crinetics Pharmaceuticals
CRNX
$3.98B
– –
-45,765
ELVN icon
36
Enliven Therapeutics
ELVN
$1.24B
– –
-102,900
EWTX icon
37
Edgewise Therapeutics
EWTX
$1.59B
– –
0
NAMS icon
38
NewAmsterdam Pharma
NAMS
$3.92B
– –
-54,285
NVO icon
39
Novo Nordisk
NVO
$237B
– –
-200,000
PCVX icon
40
Vaxcyte
PCVX
$5.52B
– –
-162,255
TARS icon
41
Tarsus Pharmaceuticals
TARS
$2.83B
– –
-20,811
XBI icon
42
SPDR S&P Biotech ETF
XBI
$6.22B
– –
0
TECX
43
Tectonic Therapeutic
TECX
$331M
– –
-16,650
1
2